Medical and pharmaceutical preparations for the treatment of myelofibrosis and muscular dystrophy, both prescription and over-the-counter, for use in connection with humans

'connect':23 'counter':19 'dystrophi':12 'human':25 'medic':1 'muscular':11 'myelofibrosi':9 'over-the-count':16 'pharmaceut':3 'prepar':4 'prescript':14 'treatment':7 'use':21

[ Consulting services relating to regulatory compliance in the pharmaceutical industry; consulting services in the field of pharmaceutical licensing; consulting services in the field of licensing of proprietary technologies in the pharmaceutical industry ]

'complianc':6 'consult':1,11,19 'field':15,23 'industri':10,32 'licens':18,25 'pharmaceut':9,17,31 'proprietari':27 'regulatori':5 'relat':3 'servic':2,12,20 'technolog':28

[ Testing, analysis, and evaluation of pharmaceutical products; development and evaluation of pharmaceutical test methods; consulting services in the field of testing, analysis and research of pharmaceutical products ]

'analysi':2,22 'consult':15 'develop':8 'evalu':4,10 'field':19 'method':14 'pharmaceut':6,12,26 'product':7,27 'research':24 'servic':16 'test':1,13,21

NS PHARMA

Owners

Goods & Services